logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hua Bo Pharmaceutical-B (02142.HK) spent 906,700 HKD on June 3rd to repurchase 100,000 shares.

date
05/06/2025
Smart Financial News APP reported that Hapoly-B (02142.HK) announced on June 3, 2025 that the company will repurchase 100,000 shares at a price of HK$9.03-9.08 per share, with a total investment of HK$906,700.
Latest
1 m ago
Beijing Enterprises Holding Limited (00371.HK): Zhou Xueyan appointed as executive director.
2 m ago
Hengrui Medicine (01276.HK) and its subsidiaries received drug clinical trial approval notices for injection SHR-A1811, Adalimumab injection, and Faronite Capsules.
2 m ago
Cuiwei Corporation (603123.SH): The company's main business is currently operating at a loss.
2 m ago
Spot silver rose nearly 2.5% intraday, now trading at $35.3 per ounce.
2 m ago
Spot silver reached a new high since March 2012, now trading at $35.4 per ounce, with an intraday increase of 2.6%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.